Scarica l'app Stockscreener
9.28
10.34%
-1.07
Dopo l'orario di chiusura:
9.27
-0.010
-0.11%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RXRX Giù?
Forum
Previsione
Precedente Chiudi:
$10.35
Aprire:
$10.38
Volume 24 ore:
31.23M
Relative Volume:
1.53
Capitalizzazione di mercato:
$3.63B
Reddito:
$64.60M
Utile/perdita netta:
$-377.75M
Rapporto P/E:
-5.9871
EPS:
-1.55
Flusso di cassa netto:
$-335.64M
1 W Prestazione:
-11.87%
1M Prestazione:
+34.88%
6M Prestazione:
+21.78%
1 anno Prestazione:
-24.98%
Intervallo 1D:
$9.15
$10.60
Intervallo di 1 settimana:
$9.15
$12.36
Portata 52W:
$5.60
$15.74
Recursion Pharmaceuticals Inc Stock (RXRX) Company Profile
Nome
Recursion Pharmaceuticals Inc
Settore
Industria
Telefono
(385) 269-0203
Indirizzo
41S RIO GRANDE STREET, SALT LAKE CITY
Confronta RXRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RXRX
Recursion Pharmaceuticals Inc
|
9.28 | 3.63B | 64.60M | -377.75M | -335.64M | -1.55 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Recursion Pharmaceuticals Inc Stock (RXRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-05-22 | Iniziato | Morgan Stanley | Equal-Weight |
| 2023-03-16 | Iniziato | Needham | Buy |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-04-18 | Downgrade | BofA Securities | Buy → Neutral |
| 2022-03-04 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2021-09-21 | Iniziato | Berenberg | Buy |
| 2021-05-11 | Iniziato | BofA Securities | Buy |
| 2021-05-11 | Iniziato | Goldman | Neutral |
| 2021-05-11 | Iniziato | JP Morgan | Neutral |
| 2021-05-11 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2021-05-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Recursion Pharmaceuticals Inc Borsa (RXRX) Ultime notizie
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought - AOL
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA's AI Favorite? - MSN
Top Biotech Stocks To ConsiderFebruary 20th - MarketBeat
Sudden Ascent: Is Recursion Pharmaceuticals NVIDIA’s AI Favorite? - MarketBeat
Cathie Wood Explains Why She Likes Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Biotech Stocks Worth WatchingFebruary 15th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) is the Best Performing Healthcare Stock So Far in 2025 - MSN
Recursion Pharma Accelerator Steps In to Fill Some of the Funding Gap Amid NIH Tumult - MedCity News
Backed by Recursion CEO, Altitude Lab venture aims to fill gap from NIH cuts - MM+M Online
10 Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Recursion CEO launches pre-seed fund in response to NIH cuts - BioPharma Dive
Why Jensen Huang’s Company Is Betting On Recursion Pharmaceuticals, Inc. (RXRX) - MSN
Altitude Lab Launches Pre-seed Venture Fund, Anchored by Recursion CEO Chris Gibson, Enabling SBIR-awarded Biotechs Hit by Funding Gap to Build in Salt Lake City - The Manila Times
Can This New Biotech Fund Save 1,500 Startups Hit by SBIR Changes? - StockTitan
Could this Nvidia-backed growth stock be a millionaire-maker at $10? - Yahoo Finance UK
Recursion CEO: Publicly funded research built the biopharma industry. Now it needs our help - STAT
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared on Wednesday - MSN
Recursion Pharmaceuticals Stock Scores RS Ratings Over 90 - MSN
5 Stocks Jensen Huang’s Company is Betting On - Insider Monkey
Recursion Pharmaceuticals Before Q4 Earnings: How to Play the Stock - MSN
Altitude Lab's Startup Portfolio Hits $154M Milestone: Inside the Biotech Incubator's Success Story - StockTitan
25 Top AI Stocks That Could Boost Your Portfolio - The Motley Fool
SoftBank Joins Nvidia In Backing Recursion Pharma, Retail Traders Rally Behind Stock Surge - NewsBreak
Nvidia-Backed Recursion Pharma Hits 3-Week High, Sparks Retail Buzz Amid Broader AI Hype - MSN
Best Biotech Stocks To Keep An Eye OnFebruary 14th - MarketBeat
Promising Mid Cap Stocks To Add to Your WatchlistFebruary 16th - MarketBeat
The Rise of Recursion Pharmaceuticals: A Biotech Stock on the Move - RagingBull
Promising Biotech Stocks To Follow NowFebruary 17th - MarketBeat
Why Recursion Pharmaceuticals, Inc. (RXRX) Soared Last Week - MSN
SoftBank reports new stakes in PacBio, Recursion Pharmaceuticals - MSN
Recursion Pharmaceuticals (NASDAQ: RXRX) Surges Nearly 24% as Nvidia Retains Stake – market - HPBL
Recursion Pharmaceuticals Stock Soars as Nvidia Maintains Stake – A Vote of Confidence? – market - HPBL
Recursion Pharmaceuticals (RXRX) Sees Institutional Investors Adjust Positions Amid Market Volatility - HPBL
Institutional Investors Bet Big on Recursion Pharmaceuticals (RXRX) Amid Growing Biotech Interest - HPBL
Why Recursion Pharmaceuticals (RXRX) Skyrocketed 23.88% on Friday – market - HPBL
Recursion Pharmaceuticals (RXRX): A Biotech Stock Outpacing the Market with Explosive Growth - HPBL
Recursion Pharmaceuticals (RXRX) Stock Surges 15%: Nvidia’s Vote of Confidence Sparks AI Biotech Rally - HPBL
Recursion Pharmaceuticals Stock Surges 15.8% as Nvidia Retains Stake – market - HPBL
Mirae Asset Global Investments Co. Ltd. Sells 74,818 Shares of Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) - MarketBeat
Shares of 10 Firms Soar on Friday - Insider Monkey
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading Up 8.6%What's Next? - MarketBeat
Why Recursion Pharmaceuticals Inc. (RXRX) Soared on Friday? - MSN
Recursion Pharmaceuticals (NASDAQ:RXRX) Trading 8.6% HigherWhat's Next? - MarketBeat
Recursion Pharmaceuticals (RXRX) Laps the Stock Market: Here's Why - MSN
Best Mid Cap Stocks To Follow TodayFebruary 14th - MarketBeat
Why Recursion Pharmaceuticals Stock Is Soaring Today - MSN
Best Pharmaceutical Stocks To Watch NowFebruary 14th - MarketBeat
Cathie Wood Doubles Down on 3D Systems, Blade Air Mobility, and Recursion Pharmaceuticals: Key Moves for Ark Invest – market - HPBL
SoftBank Latest Moves: Major Stakes in PacBio, Recursion Pharmaceuticals and Better Home & Finance - HPBL
Recursion Pharmaceuticals (RXRX) Stock Soars 15.8%, Nvidia Confidence Boosts Investor Sentiment - HPBL
Recursion Pharmaceuticals Soars 15.8% Amid Nvidia Confidence Boost – market - HPBL
Recursion Pharmaceuticals Inc Azioni (RXRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.27%
3.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):